<html>
<head>PUBMED IDs for Car3</head>
<body bgcolor='#C5F0F2'><h1>Car3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/10738106/'>Absence of evidence for allelic loss or allelic gain for ERCC1 or for XPD in human ovarian cancer cells and tissues.</a> March 30  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/15000521/'>Modulation and pharmacology of low voltage-activated (&quot;T-Type&quot;) calcium channels.</a> March 6  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15000495/'>Molecular response of follicular lymphoma to cyclophosphamide, doxorubicin, vincristine, prednisone C(H)OP or COP-based therapy as measured by polymerase chain reaction evidence of translocation (14;18)(q32;q21).</a> March 6  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15000492/'>Thrombospondin-1 acts as a fence to inhibit angiogenesis that occurs during cervical carcinogenesis.</a> March 6  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15000491/'>A clue to the therapy of neurofibromatosis type 2: NF2/merlin is a PAK1 inhibitor.</a> March 6  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/16865284/'>Gene expression profile of DNA binding protein A transgenic mice.</a> July 26  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17646949/'>Sexually dimorphic gene expression in the heart of mice and men.</a> July 25  2007<br></body></html>
